Infertility affects approximately 50 million couples worldwide; one-half of the cases are due to a male factor. The majority of infertile males are diagnosed with spermatogenic failure (SF) (Krausz & Casamonti, 2017). Azoospermia is a main known genetic factor contributing to male infertility, which is associated with the onset of 25% male infertility. However, the identified genetic abnormalities in other semen and aetiological categories is rising (Krausz & Riera-Escamilla, 2018). Azoospermia, defined as the absence of spermatozoa in the ejaculate, is a severe state of SF, affecting approximately 7% of men worldwide (Cannarella et al., 2019). Genetic disorders, including chromosomal abnormalities, genomic instability and gene mutations, are considered the most important causes of azoospermia (Ghieh et al., 2019).Copy number variations (CNVs), a significant source of genomic instability (microdeletions and/or duplications) in the Y chromosome, contribute to the development of several pathologic variations, such as spermatogenic failure and male infertility. Owing to the high proportion of segmental duplications, the Y chromosome exhibits the most significant CNVs of all human chromosomes (Liu et al., 2021). Over the last decade, Y-chromosome microdeletions have been extensively reported (Alksere et al., 2019;Araujo et al., 2020). These microdeletions are clustered in a